EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Microbiota and Nutritional Changes Following a Low-FODMAP Diet in Patients with Ulcerative Colitis and Irritable Bowel Syndrome: A Randomized Controlled Trial

Viridiana Montsserrat Mendoza-Martínez iD, Karen Lorena de León-Barrera, Guillermo Meléndez-Mier iD, Marcela Esquivel-Velázquez iD, Alberto Piña-Escobedo, Jaime García-Mena iD, Juan Manuel Vélez-Ixta iD, Martha Alison Santoyo-Chávez, Jorge Luis De-León-Rendón, Alejandro González-Tapia, Nallely Bueno-Hernández iD

Microorganisms · 28.07.2026 · 14 (8) · 1643

DOI: 10.3390/microorganisms14081643 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Microorganisms, online erschienen am 28.07.2026. Verfasst von Viridiana Montsserrat Mendoza-Martínez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics and Metabolomics Laboratory, Research Division, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI) Mexico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The low-FODMAP diet (LFD) reduces gastrointestinal symptoms, restricting poorly absorbed short-chain carbohydrates to reduce colonic fermentation. It has been proposed as a dietary strategy for irritable bowel syndrome (IBS) and ulcerative colitis (UC) patients. However, this diet could affect patients’ nutritional status and alter their gut microbiota. We aimed to evaluate the effects of a 10-week LFD on nutritional status, quality of life, and gut microbiota in patients with IBS, UC, and a control group without gastrointestinal symptoms. A randomized, single-blind clinical trial was conducted, including adults with IBS and UC, as well as a control group. Participants were randomly assigned to receive either an LFD or a standard diet (STD). Nutritional status, stool consistency, bowel habits, and quality of life were assessed, and stool samples were collected. Stool microbiota was profiled by 16S rRNA gene sequencing (V3) and analyzed for alpha diversity, beta diversity and differential abundance. Body composition was assessed by bioelectrical impedance. The follow-up period lasted 10 weeks (W0 to W10). Analyses were conducted in the per-protocol population. In total, 86 patients were included (IBS n = 40, UC n = 34, Control n = 12) with an average age of 40 ± 11 years. After adjustment for baseline values, no statistically significant differences in anthropometric or body-composition outcomes were observed between the LFD and STD groups. Similarly, there was a notable reduction in diarrhea frequency (53.3% vs. 20%, p = 0.058). Additionally, patients with IBS and UC exhibited similar microbiota profiles at W0. Among UC patients following the LFD, there was increased presence of BX12, CAG-1427, Holdemania, Evtepia, and Granulicatella, while Angelakisella and CAG-177 were less abundant. LFD was associated with changes in stool consistency, bowel habits, quality of life, and gut microbiota in patients with UC and IBS.

Schlagwörter

Stichwörter der Autor:innen

FODMAPgastrointestinal microbiomeirritable bowel syndromenutritionulcerative colitis

Autor:innen und Institutionen

  • Proteomics and Metabolomics Laboratory, Research Division, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico.
  • Faculty of Public Health and Nutrition (FASPyN), Universidad Autónoma de Nuevo León, Monterrey 66455, Mexico.
  • Departamento de Genética y Biología Molecular, Cinvestav, Av. Instituto Politécnico Nacional, Mexico City 07360, Mexico.
  • Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
  • Inflammatory Bowel Disease Clinic, Coloproctology Service, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06720, Mexico.

ORCID-Profile: Viridiana Montsserrat Mendoza-Martínez, Guillermo Meléndez-Mier, Marcela Esquivel-Velázquez, Jaime García-Mena, Juan Manuel Vélez-Ixta, Nallely Bueno-Hernández

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI) Mexico

Zitieren

APA

Mendoza-Martínez, V. M., de León-Barrera, K. L., Meléndez-Mier, G., Esquivel-Velázquez, M., Piña-Escobedo, A., García-Mena, J., Vélez-Ixta, J. M., Santoyo-Chávez, M. A., De-León-Rendón, J. L., González-Tapia, A., & Bueno-Hernández, N. (2026). Microbiota and Nutritional Changes Following a Low-FODMAP Diet in Patients with Ulcerative Colitis and Irritable Bowel Syndrome: A Randomized Controlled Trial. Microorganisms, 14(8), 1643. https://doi.org/10.3390/microorganisms14081643

Vancouver

Mendoza-Martínez VM, de León-Barrera KL, Meléndez-Mier G, Esquivel-Velázquez M, Piña-Escobedo A, García-Mena J, et al. Microbiota and Nutritional Changes Following a Low-FODMAP Diet in Patients with Ulcerative Colitis and Irritable Bowel Syndrome: A Randomized Controlled Trial. Microorganisms. 2026;14(8):1643. doi:10.3390/microorganisms14081643

BibTeX
@article{MendozaMartnez2026,
  author = {Mendoza-Martínez, Viridiana Montsserrat and de León-Barrera, Karen Lorena and Meléndez-Mier, Guillermo and Esquivel-Velázquez, Marcela and Piña-Escobedo, Alberto and García-Mena, Jaime and Vélez-Ixta, Juan Manuel and Santoyo-Chávez, Martha Alison and De-León-Rendón, Jorge Luis and González-Tapia, Alejandro and Bueno-Hernández, Nallely},
  title = {Microbiota and Nutritional Changes Following a Low-FODMAP Diet in Patients with Ulcerative Colitis and Irritable Bowel Syndrome: A Randomized Controlled Trial},
  journal = {Microorganisms},
  year = {2026},
  volume = {14},
  number = {8},
  pages = {1643},
  doi = {10.3390/microorganisms14081643}
}
Kostenlos starten →